Recherchiere Firmenbekanntmachungen und finanzielle Kennzahlen
EU-Förderung (3.996.150 €): FAIRplus Hor01.01.2019 EU-Rahmenprogramm für Forschung und Innovation "Horizont"
Auf einen Blick
Text
FAIRplus
Wide sharing of knowledge and data drives the progression of science. Shared data allows other researchers to reproduce findings and benchmark quality of experiments. Sharing data so that other researchers can Find, Access and Interoperate – i.e. integrate the data with the outcomes of their own experiments - allows Reuse and an opportunity to build the large aggregated cohorts we need to detect rare signals and manage the many confounding factors in translational research. This project will develop the guidelines and tools needed to make data FAIR. Through worked examples using IMI and EFPIA data and application and extension of existing methods we will improve the level of discovery, accessibility, interoperability and reusability of selected IMI and EFPIA data. In addition, through disseminated guidelines and tailored training for data handlers in academia, SMEs and pharmaceuticals, data management culture will change and be sustained and datasets will be reused by pharmaceutical companies, academia and SMEs. Our FAIR SME & Innovation programme will enable wide data reuse and foster an innovation ecosystem around these data that power future re-use, knowledge generation, and societal benefit. We call this approach ‘FAIRplus’.
Geförderte Unternehmen:
| Firmenname | Förderungssumme |
| Astrazeneca AB | 0,00 € |
| BAYER AG | 0,00 € |
| 0,00 € | |
| Barcelona Supercomputing Center Centro Nacional de Supercomputacion | 190.306 € |
| 855.639 € | |
| Eli Lilly and Company Ltd. | 0,00 € |
| FRAUNHOFER GESELLSCHAFT ZUR FORDERUNG DER ANGEWANDTEN FORSCHUNG e. V. | 401.130 € |
| Fundacio Institut Hospital del Mar D Investigacions Mediques | 162.384 € |
| 0,00 € | |
| Heriot-Watt University | 70.488 € |
| Imperial College of Science Technology and Medicine | 235.255 € |
| Institut National de la Sante et de la Recherche Medicale | 0,00 € |
| Janssen Pharmaceutica N.V. | 0,00 € |
| NOVARTIS PHARMA AG | 0,00 € |
| Open Phacts Foundation LBG | 211.938 € |
| SIB SWISS INSTITUTE OF BIOINFORMATICS | 191.838 € |
| Stichting Lygature | 221.544 € |
| 209.435 € | |
| The Chancellor, Masters and Scholars of the University of Oxford | 304.825 € |
| The University of Manchester | 281.418 € |
| Universite DU Luxembourg | 294.038 € |
| Universite Paul Sabatier Toulouse III | 107.514 € |
| Universiteit Maastricht | 258.401 € |
Quelle: https://cordis.europa.eu/project/id/802750
Diese Bekanntmachung wurde von Englisch nach Deutsch übersetzt. Die Bekanntmachung bezieht sich auf einen vergangenen Zeitpunkt, und spiegelt nicht notwendigerweise den heutigen Stand wider.
Die Visualisierungen zu "Astrazeneca AB - EU-Förderung (3.996.150 €): FAIRplus"
werden von
North Data
zur Weiterverwendung unter einer
Creative Commons Lizenz
zur Verfügung gestellt.
